Company Filing History:
Years Active: 2012
Title: Giovanni Mario Pitari: Innovator in Cancer Treatment
Introduction
Giovanni Mario Pitari is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of cancer research. His work primarily focuses on the treatment and detection of colorectal cancer, utilizing innovative methods to enhance therapeutic outcomes.
Latest Patents
Pitari holds a patent for the use of GCC ligands, which inhibit the proliferation of colorectal, gastric, and esophageal cancer cells. The patent details a method where the number of ST receptor molecules on the surface of colorectal cells is increased by administering an ST receptor ligand. This ligand interacts with the ST receptor, facilitating the treatment or imaging of metastasized colorectal cancer. The pharmaceutical compositions described in the patent include sterile, pyrogen-free ST receptor ligands combined with a pharmaceutically acceptable carrier or diluent. Additionally, the patent outlines methods for detecting metastasized colorectal cancer and delivering active compounds to colorectal cells in individuals.
Career Highlights
Giovanni Mario Pitari is affiliated with Thomas Jefferson University, where he continues to advance his research in cancer treatment. His innovative approaches have the potential to significantly impact the medical field, particularly in oncology.
Collaborations
Pitari has collaborated with esteemed colleagues such as Scott A. Waldman and Jason Park, contributing to a rich environment of research and innovation.
Conclusion
Giovanni Mario Pitari's work exemplifies the intersection of innovation and medical research, particularly in the fight against colorectal cancer. His contributions through patents and collaborations highlight the importance of continued research in this critical area of health.